Navigation Links
MYOLYN Announces FDA Clearance of its MyoCycle Device
Date:4/26/2017

MYOLYN, a medical technology company dedicated to improving health and human performance, is proud to announce that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two of its cutting-edge technologies, the MyoCycle Home and the MyoCycle Pro.

Both devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation (FES) technology to empower anyone who has difficulty activating their own muscles. Such systems are also known as FES bikes.

Clearance from the FDA marks a major milestone for the technology startup, allowing MYOLYN to enter both the professional rehabilitation and the homecare medical device markets.

“FES is a very promising technology that can help many people with paralysis or muscle weakness,” says MYOLYN co-founder and CEO Alan Hamlet, PhD. “MYOLYN’s goal is to make this revolutionary technology available to the millions of people that can benefit from it. The MyoCycle is an affordable, easy-to-use FES bike that enables therapeutic, load-bearing exercise despite even complete paralysis. It is a game changer!”

An FES bike is essentially a stationary exercise bike that someone who is paralyzed can use because it activates their muscles for them. The MyoCycle is intended for general rehabilitation for relaxing muscle spasms, preventing muscle atrophy, increasing blood circulation, and maintaining or increasing range of motion following disease or injury. These indications for use make the MyoCycle especially beneficial for people with spinal cord injury, stroke, multiple sclerosis, Parkinson’s disease, and cerebral palsy, as well as people undergoing orthopedic rehabilitation following knee or hip surgery.

“Our patent-pending algorithms automatically select the optimal stimulation parameters for the patient, making the MyoCycle not only effective, but extremely easy and intuitive to use,” says Chief Technology Officer Matthew Bellman, PhD. “Our goal was to make this technology practical for use in the home for the first time, so we designed the MyoCycle from the ground up to be affordable and as easy-to-use as a regular exercise bike.”

FDA clearance enables millions of people with paralysis to engage in a complete continuum of care from the clinic, where the MyoCycle Pro helps to maximize recovery potential, to the comfort of home, where the MyoCycle Home helps people with paralysis to stay active and healthy.

  • The MyoCycle Pro, intended for clinical use, combines isokinetic cycling and FES into a single system that can increase clinic revenue while maximizing patient outcomes.
  • The MyoCycle Home is an affordable, easy-to-use FES bike that empowers patients to take control of their health and get the therapy they need from the comfort of home.

For more information on MYOLYN – including the MyoCycle Pro and MyoCycle Home – please visit: http://www.myolyn.com.

###

About MYOLYN
MYOLYN’s vision is to improve health and human performance by empowering people to move. Located in Gainesville, FL, MYOLYN was founded in 2013 by founders Alan Hamlet and Matthew Bellman, both of whom received their PhD’s in robotics from the University of Florida. MYOLYN uses its unique expertise in automation to develop electrical stimulation devices that are innovative, affordable, and easy-to-use.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14279596.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. LG CNS Healthcare Solutions Announces New BYOD Capabilities in Telehealth Solution
2. Bright Pink Announces New CEO, Katie Thiede
3. Altura Communication Solutions Announces Cisco Select Certification
4. AMSA Announces New Campaign, AWARE: A Week of Addiction and Recovery Education
5. Airway Management, the manufacturer of TAP Sleep Care products, announces new partnership with Asian distributor.
6. GAOTek Announces Advanced Fiber Fusion Splicer with Large Magnification
7. RJ Young Announces Sales Team Expansion with Additional Regional Sales Manager Position
8. LG CNS Healthcare Solutions Announces Second Annual Healthcare Innovation Challenge for Telehealth
9. Amendia Announces Acquisition of Spinal Elements
10. Brewista Announces Plan to Continue Selling NutraMilk After a Successful Crowdfunding Campaign
11. symplr Announces New Version of Visitor Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... 15, 2017  AOTI Inc. announced today that its fully owned ... recently opened a New York City Office in Yonkers, ... unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This new ... for Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable ... Advanced ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology: